RetractedArticleBioengineered2022

CRISPR/Cas9 (D10A) nickase-mediated Hb CS gene editing and genetically modified fibroblast identification.

Wei-Hao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.